This PDF is the current document as it appeared on Public Inspection on 02/23/2015 at 08:45 am.
Name: ICD-10 Coordination and Maintenance (C&M) Committee meeting.
Time and Date: 9:00 a.m.-5:00 p.m., March 18-19, 2015
Place: Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland 21244.
Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 240 people. We will be broadcasting the meeting live via Webcast at hhtp://www.cms.gov/live/.
Security Considerations: Due to increased security requirements CMS has instituted stringent procedures for entrance into the building by non-government employees. Attendees will need to present valid government-issued picture identification, and sign-in at the security desk upon entering the building.
Attendees who wish to attend the March 18-19, 2015 ICD-10-CM C&M meeting must submit their name and organization by March 13, 2015, for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by the guards to admit visitors to the meeting.
Participants who attended previous Coordination and Maintenance meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you wish attend.
Please register to attend the meeting on-line at: http://www.cms.hhs.gov/apps/events/ Please contact Mady Hue (410-786-4510 or Marilu.firstname.lastname@example.org), for questions about the registration process.
Purpose: The ICD-10 Coordination and Maintenance (C&M) Committee is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Start Printed Page 9729Tenth Revision, Clinical Modification and ICD-10 Procedure Coding System.
Matters For Discussion: Tentative agenda items include:
March 18-19, 2015
Administration of Blincyto (blinatumomab)
Administration of Idarucizumab
Coronary Orbital Atherectomy
Administration of CRESEMBA (Isavuconazonium)
Insertion of Tibial Insert
Removal of Thrombus and Emboli
Organ Perfusion for Transplants
Creation of Atrial Septal Defect
Pediatric Congenital Heart Procedures
Modified Blalock-Taussig Shunt
Arterial Switch Operation
Repair of Complete Common
Atrioventricular Canal Defect
Truncus Arteriosus Repair
Balloon Atrial Septostomy
Addenda and Key Updates
ICD-10-PCS X Code
ICD-10 MS-DRGs Impact Update
End to End Testing
ICD-10-CM Diagnosis Topics:
Vaccine and prophylactic immunotherapy administration
External cause codes for over exertion; repetitive motion
Acute Kidney Injury (AKI)
Chronic Kidney Disease (CKD)
Hepatic Encephalopathy (HE)
Exocrine Pancreatic Insufficiency
Childhood Asymmetric Labium Majus Enlargement (CALME)
Longitudinal Vaginal Septum
Prepubertal Vaginal Bleeding
Interruption of Aortic Arch
Congenital malformations of aorta
Observation and evaluation of newborns for suspected and ruled-out conditions
Agenda items are subject to change as priorities dictate.
CMS and NCHS no longer provide paper copies of handouts for the meeting. Electronic copies of all meeting materials will be posted on the CMS and NCHS Web sites prior to the meeting at http://www.cms.hhs.gov/ICD9ProviderDiagnosticCodes/03_meetings.asp#TopOfPage and http://www.cdc.gov/nchs/icd/icd9cm_maintenance.htm.
Contact Persons For Additional Information: Donna Pickett, Medical Systems Administrator, Classifications and Public Health Data Standards Staff, NCHS, 3311 Toledo Road Hyattsville, Maryland 20782, email email@example.com, telephone 301-458-4434 (diagnosis); Mady Hue, Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security Boulevard, Baltimore, Maryland, 21244, email firstname.lastname@example.org, telephone 410-786-4510(procedures). The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry.Start Signature
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2015-03683 Filed 2-23-15; 8:45 am]
BILLING CODE 4160-18-P